Loss of p53 and Ink4a/Arf cooperate in a cell autonomous fashion to induce metastasis of hepatocellular carcinoma cells.
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide. HCC patients frequently present with disease that has metastasized to other regions of the liver, the portal vein, lymph nodes, or lungs, leading to poor prognoses. Therefore, model systems that allow exploration of the molecular mechanisms underlying metastasis in this disease are greatly needed. We describe here a metastatic HCC model generated after the somatic introduction of the mouse polyoma virus middle T antigen to mice with liver-specific deletion of the Trp53 tumor suppressor locus and show the cell autonomous effect of p53 loss of function on HCC metastasis. We additionally find that cholangiocarcinoma also develops in these mice, and some tumors display features of both HCC and cholangiocarcinoma, suggestive of origin from liver progenitor cells. Concomitant loss of the Ink4a/Arf tumor suppressor locus accelerates tumor formation and metastasis, suggesting potential roles for the p16 and p19 tumor suppressors in this process. Significantly, tumor cell lines isolated from tumors lacking both Trp53 and Ink4a/Arf display enhanced invasion activity in vitro relative to those lacking Trp53 alone. Thus, our data illustrate a new model system amenable for the analysis of HCC metastasis.
Chen
Ya-Wen
YW
Program in Gene Function and Expression, University of Massachusetts Medical School, Worcester, Massachusetts 01605, USA.
Klimstra
David S
DS
Mongeau
Michelle E
ME
Tatem
Jessica L
JL
Boyartchuk
Victor
V
Lewis
Brian C
BC
D000818:Animals; D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000172:deficiency* / Q000235:genetics; D017353:Gene Deletion; D008114:Liver Neoplasms, Experimental / Q000235:genetics / Q000473:pathology*; D008175:Lung Neoplasms / Q000556:secondary*; D051379:Mice; D008822:Mice, Transgenic; D016159:Tumor Suppressor Protein p53 / Q000172:deficiency* / Q000235:genetics
C417743:Cdkn2a protein, mouse; D019941:Cyclin-Dependent Kinase Inhibitor p16; D016159:Tumor Suppressor Protein p53
Mol Cell Biol. 1997 Sep;17(9):4967-78
9271375
J Clin Invest. 2004 Jun;113(12):1774-83
15199412
Virology. 1998 Sep 1;248(2):305-11
9721239
J Biol Chem. 1999 Jan 1;274(1):305-15
9867845
Gastroenterology. 1999 Feb;116(2):394-400
9922321
Oncogene. 1999 Jan 21;18(3):789-95
9989830
PLoS Biol. 2004 Nov;2(11):e332
15455033
Cell. 2004 Dec 17;119(6):847-60
15607980
PLoS Biol. 2005 Jan;3(1):e11
15630473
Mol Cell Biol. 2005 Feb;25(4):1228-37
15684377
Br J Cancer. 2005 Jan 31;92(2):252-8
15668718
Oncogene. 2005 Feb 17;24(8):1477-80
15608678
CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
15761078
Cell Cycle. 2005 Oct;4(10):1335-7
16177571
Am J Pathol. 2006 Apr;168(4):1155-68
16565491
Cell. 2006 Jun 30;125(7):1253-67
16814713
Cancer Cell. 2006 Aug;10(2):99-111
16904609
Nat Rev Cancer. 2006 Sep;6(9):674-87
16929323
Cell. 2000 Jan 7;100(1):57-70
10647931
Cancer. 2000 Jul 1;89(1):60-8
10897001
Semin Cancer Biol. 2000 Jun;10(3):185-200
10936068
Am J Pathol. 2000 Sep;157(3):1031-7
10980141
J Virol. 2001 Feb;75(3):1401-7
11152513
Nature. 2001 Mar 1;410(6824):50-6
11242036
J Biol Chem. 2001 Apr 27;276(17):13989-94
11278564
Nature. 2001 Sep 6;413(6851):83-6
11544530
Oncogene. 2001 Oct 25;20(48):7104-9
11704835
Nat Genet. 2001 Dec;29(4):418-25
11694875
Am J Surg Pathol. 2002 Aug;26(8):989-97
12170085
Nature. 2002 Aug 22;418(6900):823
12192390
Curr Opin Genet Dev. 2003 Feb;13(1):77-83
12573439
Nat Med. 2003 Apr;9(4):416-23
12640447
Clin Cancer Res. 2003 Jul;9(7):2657-64
12855644
Genes Dev. 2003 Dec 15;17(24):3127-38
14681205
Horm Metab Res. 2003 Nov-Dec;35(11-12):685-93
14710347
Horm Metab Res. 2003 Nov-Dec;35(11-12):802-8
14710361
Oncogene. 1997 Jan 30;14(4):395-404
9053836
Nat Genet. 1995 Jan;9(1):41-7
7704023
Curr Biol. 1994 Jan 1;4(1):1-7
7922305
Annu Rev Med. 1994;45:297-323
8198385
Cell. 1993 Sep 10;74(5):813-22
8374952
Cancer Res. 1993 Apr 15;53(8):1719-23
8467484
Nature. 1992 Mar 19;356(6366):215-21
1552940
Cell. 1990 Jun 15;61(6):1137-46
2350785
Lancet. 1989 Dec 2;2(8675):1338
2574287
Oncogene. 1989 Jun;4(6):715-24
2543942
Cancer Res. 2004 Jan 1;64(1):48-54
14729607
Cancer Res. 2004 Feb 15;64(4):1315-22
14973059
Virology. 1998 Sep 1;248(2):295-304
9721238